TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT02784041

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: single adductor-canal-block
Description: Single adductor-canal-block is performed before the surgery. A 12Hz linear ultrasound transducer is placed on the medial part of the thigh with the leg slightly externally rotated. The femoral artery was identified in short axis in the adductor canal, underneath the sartorius muscle. After skin disinfection , an 18-gauge needle (B.Braun Medical, Melsungen, Germany) is inserted in-plane from the lateral side of the transducer. The needle tip was placed underneath the sartorius muscle, just lateral to the artery and saphenous nerve, using 2-3 ml of saline to ensure correct placement. 25 ml of 0.35% ropivacaine is slowly injected with repeated aspiration.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: periarticular infiltration
Description: The periarticular infiltration of multimodal agents will involve the preparation of a mixture of 100 ml solution. The mixture contains 30ml (300mg) ropivacaine, 0.5ml (5 mg) morphine, 2 ml (50 mg) flurbiprofen and 0.5 ml of 1:1000 epinephrine, and then is diluted with 0.9% normal saline to a total volume of 100ml. 50 ml of mixture will be injected into the anterior, medial and lateral soft tissues after the implantation of the joint prostheses. The remaining 50 ml of mixture will be injected into intraarticular space after the closure of articular capsule.
Study: NCT03149276

Intervention type: OTHER
Intervention: Interpreter services
Study: NCT02847871

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: PRISME-3P program
Description: PRISM-3P program will consist on a visit in the geriatric centre:~* Consultation with the geriatrician to rule a condition associated with loss of mobility and not known until now.~* Perform a nutritional assessment by a dietician followed by appropriate care management.~* Educational activity based on exercises and physical activity and balance: MAPA teaches exercises to develop strength and balance; gives tips to increase time spent on non-sedentary activities and enhance endurance followed by a monthly phone coaching.~* At 3 months, in case of no improvement of the SPPB score of 1 point, a training of 10 weeks with two sessions per week will be perform by the MAPA individually or in small patients groups;~* Implementation of a information exchange processing (mail, phone and book binding) between the various stakeholders.
Study: NCT02442180

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF (Filgrastim injection)
Description: G-CSF (Filgrastim injection) 5ug/kg subcutaneous injection daily for 5 days and every 3 days (total 12 doses)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF (Filgrastim injection)
Description: G-CSF (Filgrastim injection) 5ug/kg subcutaneous injection daily for 5 days and every 3 days (total 12 doses)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: steroid
Description: oral prednisolone 40mg qd or iv methylprednisolone 32 mg if oral medication is not tolerable

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: steroid
Description: oral prednisolone 40mg qd or iv methylprednisolone 32 mg if oral medication is not tolerable

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: equivalent to G-CSF doses

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: equivalent to G-CSF doses
Study: NCT01563497

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-05089771
Description: Oral dispersion TS formulation- fasted

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-05089771
Description: Tablets TS formulation- fasted

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-05089771
Description: Tablets TS formulation- fed
Study: NCT02436226

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clomiphene citrate and Human chorionic gonadotropin (HCG)
Description: Women will receive clomiphene citrate (150 mg/day for 5 consecutive days from day 2 of cycle) and HCG (200 IU/day SC from day 7 of cycle)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clomiphene citrate
Description: Women will receive clomiphene citrate (150 mg/day for 5 consecutive days from day 2 of cycle)
Study: NCT02914353

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EP=7041
Description: Factor X!a Inhibitor

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Normal Saline
Study: NCT03561324

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Imaging Beta Probe (IBP)
Description: Using IBP for imaging of PET positive lymph nodes
Study: NCT02587065

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: peginterferon beta-1a
Description: 125 mcg administered subcutaneously (SC) every 2 weeks.
Study: NCT01114360

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Melatonin
Description: Melatonin (N-acetyl-5-methoxytryptamine) is an indoleamine compound. Subjects will receive 8 mg time-release melatonin pills, orally, once per night for 4 weeks.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Subjects received placebo pills (3 pills of 8 mg each) to be taken orally once per night for 4 weeks.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects received placebo pills (3 pills of 8 mg each) to be taken orally once per night for 4 weeks.
Study: NCT06351709

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stretching
Description: Static stretching technique was applied to the quadriceps and hamstring muscle groups in both the dominant and non-dominant extremities of the participants in the stretching group. All stretches were performed twice for 20 seconds with a 3-second rest.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hot pack application
Description: Hot pack application was applied to the participants in the hot group to warm the extremities locally after the pre-tests were completed. For the application of hotpack, which is a superficial and moist temperature agent, a Chattanooga ® brand hotpack pad (DJO Global, Chattanooga; CA, USA) with 10 slices and a size of 28 cm x 39 cm was used. The hotpack pad was taken with the help of tongs from the Chattanooga ® brand hot pack boiler (DJO Global, Chattanooga; CA, USA) at 80° temperature and wrapped in a total of 5 layers with the help of 2 towels. A hotpackpad was placed on each knee of the participant. Hotpack pads were applied for 15 minutes in total.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cold pack application
Description: For participants in the cold group, MSD ® brand cold pack gel (MVS Inmotion, MSD cold pack; Weftdijk 1502830, Belgium), 15 cm x 25 cm in size, was used to cool the extremities locally. The cold pack gel, kept in the freezer, was wrapped in a paper towel and placed on the knee area. Cold pack was applied to both knees for a total of 15 minutes.
Study: NCT05908968

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: ELO water
Description: Drinking 1.5 litres daily of ELO water for 12 weeks
Study: NCT03692481

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 18FDG-PET scan
Description: 18FDG PET scan will be performed in each patient before initiation of pirfenidone and after 12 weeks of treatment
Study: NCT03619226

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: test patch
Description: the test patch consists of an adhesive patch
Study: NCT02723370

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Staff multi-component implementation strategy
Description: Staff will receive a multi-component implementation strategy for evidence based practices (EBPs) for colonoscopy, including split-dosing of bowel preparation, low literacy education materials for patients, and teach-back procedure. The implementation strategy includes a supply of low-literacy patient education materials for split-dosing the medication of their choice, poster and pocket-card with teach-back prompts, consultation to integrate materials and teach-back into workflow and a website with additional training and patient materials.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Staff multi-component implementation strategy
Description: Staff will receive a multi-component implementation strategy for evidence based practices (EBPs) for colonoscopy, including split-dosing of bowel preparation, low literacy education materials for patients, and teach-back procedure. The implementation strategy includes a supply of low-literacy patient education materials for split-dosing the medication of their choice, poster and pocket-card with teach-back prompts, consultation to integrate materials and teach-back into workflow and a website with additional training and patient materials.
Study: NCT03605069

Intervention type: DRUG
Group type: OTHER
Intervention: QR-313
Description: QR-313 will be applied topically once daily for 8 weeks of treatment.

Intervention type: DRUG
Group type: OTHER
Intervention: QR-313
Description: QR-313 will be applied topically once daily for 8 weeks of treatment.

Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: Placebo will be applied topically once daily for 8 weeks of treatment.

Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: Placebo will be applied topically once daily for 8 weeks of treatment.
Study: NCT02811783

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Naloxone Hydrochloride Lotion, 0.5%
Description: Topical TID for 2 weeks
Study: NCT03647865

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Osseous Genioplasty
Description: Surgical Procedure that cuts the chin and reposition it in the correct place
Study: NCT01421758

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: online social network enrollment plus education and self monitoring
Description: Participants are enrolled in an online social network designed to increase social support for physical activity and will self monitor physical activity and receive educational materials at a dedicated study website.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Web education control
Description: Participants will receive access to a dedicated study website where they can view educational materials related to physical activity
Study: NCT04023448

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: transverse coloplasty pouch
Description: a transverse coloplasty pouch was performed before end to end colon-rectum (or anal canal) anastomosis
Study: NCT04989400

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ulipristal Acetate
Description: Group A: received Ulipristal acetate 30mg, starting misoprostol 12 hours later 100µg every 6 hours buccal. Then women in had rest for 24 hours after 5 doses of misoprostol and restarted misoprostol-only in both groups with the same above regimens, repeating the same sequence for two weeks unless there was excessive bleeding or infection or uterine contractions or cervical changes. If failed, patient proceeded to hysterotomy. If patient aborted, an obstetric US was done to assess the presence of remnants in the uterine cavity. Patient with remnants of conception proceeded suction evacuation.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Misoprostol
Description: Group A: received Ulipristal acetate 30mg, starting misoprostol 12 hours later 100µg every 6 hours buccal.Group B: received placebo tablet of same shape , texture of that of ulipristal then 12 hours later start misoprostol 100µg every 6 hours buccal. Then women in both groups had rest for 24 hours after 5 doses of misoprostol and restarted misoprostol-only in both groups with the same above regimens, repeating the same sequence for two weeks unless there was excessive bleeding or infection or uterine contractions or cervical changes. If failed, patient proceeded to hysterotomy. If patient aborted, an obstetric US was done to assess the presence of remnants in the uterine cavity. Patient with remnants of conception proceeded suction evacuation.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Misoprostol
Description: Group A: received Ulipristal acetate 30mg, starting misoprostol 12 hours later 100µg every 6 hours buccal.Group B: received placebo tablet of same shape , texture of that of ulipristal then 12 hours later start misoprostol 100µg every 6 hours buccal. Then women in both groups had rest for 24 hours after 5 doses of misoprostol and restarted misoprostol-only in both groups with the same above regimens, repeating the same sequence for two weeks unless there was excessive bleeding or infection or uterine contractions or cervical changes. If failed, patient proceeded to hysterotomy. If patient aborted, an obstetric US was done to assess the presence of remnants in the uterine cavity. Patient with remnants of conception proceeded suction evacuation.
Study: NCT00798538

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Services will be provided at one site
Description: Provision of buprenorphine induction and management, substance abuse counseling and HIV care will be provided at one clinic: the Waterbury Hospital Infectious Disease Clinic..
Study: NCT02811783

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Lotion
Description: Topical TID for 2 weeks
Study: NCT03165214

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: coil
Description: microcoils

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: hystoacryl glue
Description: hystoacryl mixed with lipidol
Study: NCT00002514

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: sargramostim

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: asparaginase

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: asparaginase

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cyclophosphamide

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cytarabine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cytarabine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: daunorubicin hydrochloride
Study: NCT00798538

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Services remain dispersed; i.e., not centralized to one-location or provider.
Description: Buprenorphine induction, substance abuse counseling, and HIV care will be provided at separate locations: the Community Health Care Van (CHCV), the Yale AIDS Program, and patients' own HIV providers, respectively.
Study: NCT02824250

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MBSR
Description: Mindfulness-Based Stress Reduction (MBSR) is an 8-week classroom based program of mindfulness meditation and gentle yoga.
Study: NCT00002514

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: daunorubicin hydrochloride

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dexamethasone

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: etoposide

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: etoposide

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: imatinib mesylate

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: leucovorin calcium

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: leucovorin calcium

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: mercaptopurine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mercaptopurine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: methotrexate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methotrexate

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: prednisone

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: prednisone

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: thioguanine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: vincristine sulfate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vincristine sulfate

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: allogeneic bone marrow transplantation

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: autologous bone marrow transplantation

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: peripheral blood stem cell transplantation

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: radiation therapy
Study: NCT01800656

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoloop-assisted ligate and let go colorectal polypectomy
Description: The technique implies placement of endoloop snare on the base of large pedunculated colorectal polyps without consecutive snare polypectomy.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endoloop-assisted snare colorectal polypectomy
Description: The technique implies placement of endoloop snare on the base of large pedunculated colorectal polyps with consecutive snare polypectomy.
Study: NCT02044666

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Micronized Small Intestinal Submucosa (SIS)
Description: Micronized Small Intestinal Submucosa (SIS)
Study: NCT02259140

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Proximal Femoral Resection Arthroplasty
Description: Drains will be placed at the surgeon's discretion. Patients will be placed in skin traction on the operative side. Post-operative bracing or casting will be at the surgeon's discretion. All patients will receive standardized post-operative prophylactic radiation to minimize heterotopic ossification.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Subtrochanteric Valgus Osteotomy
Description: Drains will be placed at the surgeon's discretion. Post-operative bracing or casting will be at the surgeon's discretion. All patients will receive standardized post-operative prophylactic radiation to minimize heterotopic ossification.
Study: NCT00895687

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erlotinib Hydrochloride
Description: Beginning dose of 150 mg taken by mouth daily for 21-day cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bortezomib
Description: Beginning dose of 1. mg/m\^2 by vein over about 1-5 minutes on Days 1, 4, 8, and 11 of each 21-day cycle.
Study: NCT01063842

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: tramadol hydrochloride /acetaminophen
Description: 1 tablet of tramadol hydrochloride/acetaminophen three times daily without titration for 14 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tramadol hydrochloride / acetaminophen and placebo
Description: 1 tablet of tramadol/acetaminophen in the morning, 1 tablet of placebo in the afternoon and evening for 3 days, then 1 tablet of tramadol/acetaminophen in the morning, evening and 1 tablet of placebo in the afternoon for 4 days, then 1 tablet of tramadol/acetaminophen 3 times daily for next 7 days
Study: NCT00673881

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: choline fenofibrate
Description: 135 mg choline fenofibrate daily(oral, capsule)
Study: NCT02510183

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Acupressure Wrist Band
Description: Acupressure wrist band is a knitted elasticated wrist band, which operates by applying pressure on the P6 acupressure point on each wrist by means of a plastic stud.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Acupressure Wrist Band
Description: Placebo Acupressure Wrist Band is a knitted elasticated wrist band without a plastic stud.
Study: NCT00278330

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: alvocidib
Description: Given by infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vorinostat
Description: Given orally
Study: NCT02342379

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: 10mg/kg
Study: NCT05904002

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pulmicort inhaler
Description: Each woman in both groups (A\&B) will receive pulmicort inhaler on needs.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pulmicort inhaler
Description: Each woman in both groups (A\&B) will receive pulmicort inhaler on needs.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Incentive spirometer treatment
Description: Each patient in group B will be instructed about the effects of incentive spirometer to gain their cooperation during the study course.
Study: NCT04736225

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Insulin Self-Titration Education Program
Description: The program contents of instruction included blood glucose self-monitoring, types of insulin, insulin self-administration, insulin dose titration, hyperglycemia or hypoglycemia self-management, diet, and exercise.a 20-min one-on-one training session from a nurse on how to self-titrate the insulin dose. The participants were taught to monitor their before-breakfast and before-dinner blood glucose levels at home and adjust their insulin doses accordingly.
Study: NCT02342379

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TH-302
Description: 670mg/m2
Study: NCT01895244

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells
Description: If no active alveolitis: mobilisation with 2x1g Cyclophosphamide If active alveolitis: mobilisation with 2x1.5g Cyclophosphamid If cardiac manifestation: Conditioning with CYC 2 x 50mg + thiotepa 2x5mg + ATG If no cardiac manifestation: Conditioning with 4 x 50mg CYC + ATG

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells
Description: If no active alveolitis: mobilisation with 2x1g Cyclophosphamide If active alveolitis: mobilisation with 2x1.5g Cyclophosphamid If cardiac manifestation: Conditioning with CYC 2 x 50mg + thiotepa 2x5mg + ATG If no cardiac manifestation: Conditioning with 4 x 50mg CYC + ATG
Study: NCT01719003

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin 500 mg bid
Description: Metformin 500 mg twice daily
Study: NCT03816059

Intervention type: DIAGNOSTIC_TEST
Intervention: Respiratory virus testing
Description: All patients will be tested for respiratory viruses

Intervention type: DIAGNOSTIC_TEST
Intervention: Respiratory virus testing
Description: All patients will be tested for respiratory viruses
Study: NCT02958553

Intervention type: DEVICE
Group type: OTHER
Intervention: emPOWER Ankle
Description: The device is 510k cleared and is intended to replace a missing foot and ankle. The emPOWER Ankle is to be used exclusively for fittings of lower-extremity amputations as prescribed by a healthcare professional.
Study: NCT04736225

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Insulin Self-Titration Education Program
Description: The program contents of instruction included blood glucose self-monitoring, types of insulin, insulin self-administration, insulin dose titration, hyperglycemia or hypoglycemia self-management, diet, and exercise.a 20-min one-on-one training session from a nurse on how to self-titrate the insulin dose. The participants were taught to monitor their before-breakfast and before-dinner blood glucose levels at home and adjust their insulin doses accordingly.